Clopidogrel, as an ADP receptor antagonist, prevents ADP from binding to ADP receptors on platelets and prevents glycoprotein IIb/IIIa receptors from binding to fibrinogen, thereby inhibiting platelet aggregation. It is used to prevent and treat heart, brain and other arterial circulatory disorders caused by high platelet aggregation, such as recent strokes, myocardial infarction and confirmed peripheral arterial diseases.

Fasudil, as the first Rho kinase inhibitor to be used in clinical practice, can inhibit the final stage of vascular smooth muscle contraction with dual targets, and target the movement of inflammatory cytoskeleton proteins to prevent and treat vasospasm. Interventional partner for the treatment of cerebral vasospasm. The treatment is targeted, safe, and does not affect systemic blood pressure.

Sodium ferulate is the sodium salt of ferulic acid, which is the main component of angelica sinensis, a traditional Chinese medicine for promoting blood circulation to remove blood stasis. The sodium ferulate injection compounded by using modern technology, not only retains the effect of promoting blood circulation to remove blood stasis of angelica sinensis, but gives a new connotation. The endothelin receptor antagonists are oxidation resistant, which can clear free radicals, and prevent platelet aggregation, with anti-inflammatory and immune adjustments, increasing blood creation function.

This product is a medicine with a stronger biological effect obtained by structural modification of the main active component - propyl gallate, on the basis of in-depth study of paeoniae radix rubra, a traditional Chinese medicine used for promoting blood circulation to remove blood stasis. This product can significantly inhibit platelet aggregation; enhance fibrinolytic activity, promote thrombolysis; reduce whole blood viscosity and plasma specific viscosity;